The United States is the world’s preeminent biopower—the nation best able to harness emerging biotechnologies to fortify national and economic security. But America’s position is far from assured, with China rapidly closing the gap. The Tech Program conducts innovative policy research to secure America’s biotechnology leadership by responsibly unlocking the potential of biodata, building a robust biomanufacturing defense industrial base, and crafting international partnerships with biotechnology-leading allies and partners.
Biotechnology Team
-
Vivek Chilukuri
Senior Fellow and Director, Technology and National Security Program
-
Sam Howell
Associate Fellow, Technology and National Security Program
-
Michelle Holko, PhD, PMP
Adjunct Senior Fellow, Technology and National Security Program
Highlights
-
Biopower
Reports
For policymakers, the question is not whether the biorevolution has transformative power, but which nation will responsibly harness that power...
By Vivek Chilukuri & Hannah Kelley
-
Biotech Matters
Reports
Operation Warp Speed showed the power of the U.S. government to direct national biotech capabilities around a shared goal—in this case, a novel vaccine. But there are many oth...
By Hannah Kelley
-
Make America the Biopower
Commentary
No country has a better biotechnology hand than America. The administration has a historic opportunity to play it wisely and secure the United States’ position as the 21st cen...
By Vivek Chilukuri
